FDA
approval
· 2017-05-23
FDA Approved: BUPRENORPHINE — Supplemental Application (Rhodes Pharmaceuticals L.P.)
Summary
FDA approved a supplemental application for buprenorphine from Rhodes Pharmaceuticals L.P., indicating regulatory action on an existing product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for BUPRENORPHINE (BUPRENORPHINE)